CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,893 | +61.1% | 31,984 | +85.2% | 0.01% | +55.6% |
| Q2 2023 | $232,096 | -91.1% | 17,269 | -89.0% | 0.01% | -91.7% |
| Q1 2023 | $2,598,451 | +76.1% | 156,722 | +97.6% | 0.11% | +38.5% |
| Q4 2022 | $1,475,519 | +142.3% | 79,329 | +67.0% | 0.08% | +225.0% |
| Q3 2022 | $609,000 | +6.1% | 47,500 | -42.0% | 0.02% | -4.0% |
| Q2 2022 | $574,000 | -33.1% | 81,901 | -20.9% | 0.02% | -32.4% |
| Q1 2022 | $858,000 | +3.5% | 103,494 | -15.4% | 0.04% | -28.8% |
| Q4 2021 | $829,000 | +278.5% | 122,400 | +222.2% | 0.05% | +147.6% |
| Q2 2021 | $219,000 | -13.8% | 37,983 | -31.1% | 0.02% | -12.5% |
| Q1 2021 | $254,000 | +62.8% | 55,100 | +5.0% | 0.02% | -22.6% |
| Q3 2020 | $156,000 | – | 52,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |